226 related articles for article (PubMed ID: 23932155)
1. HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1.
Busch CJ; Kriegs M; Laban S; Tribius S; Knecht R; Petersen C; Dikomey E; Rieckmann T
Radiother Oncol; 2013 Sep; 108(3):495-9. PubMed ID: 23932155
[TBL] [Abstract][Full Text] [Related]
2. G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1.
Busch CJ; Kröger MS; Jensen J; Kriegs M; Gatzemeier F; Petersen C; Münscher A; Rothkamm K; Rieckmann T
Radiother Oncol; 2017 Feb; 122(2):260-266. PubMed ID: 27939202
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines.
Güster JD; Weissleder SV; Busch CJ; Kriegs M; Petersen C; Knecht R; Dikomey E; Rieckmann T
Radiother Oncol; 2014 Dec; 113(3):345-51. PubMed ID: 25467050
[TBL] [Abstract][Full Text] [Related]
4. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity.
Rieckmann T; Tribius S; Grob TJ; Meyer F; Busch CJ; Petersen C; Dikomey E; Kriegs M
Radiother Oncol; 2013 May; 107(2):242-6. PubMed ID: 23602369
[TBL] [Abstract][Full Text] [Related]
5. Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells.
Hintelmann K; Berenz T; Kriegs M; Christiansen S; Gatzemeier F; Struve N; Petersen C; Betz C; Rothkamm K; Oetting A; Rieckmann T
Front Oncol; 2021; 11():683688. PubMed ID: 34354944
[TBL] [Abstract][Full Text] [Related]
6. Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis.
Arenz A; Ziemann F; Mayer C; Wittig A; Dreffke K; Preising S; Wagner S; Klussmann JP; Engenhart-Cabillic R; Wittekindt C
Strahlenther Onkol; 2014 Sep; 190(9):839-46. PubMed ID: 24715240
[TBL] [Abstract][Full Text] [Related]
7. Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints.
Molkentine JM; Molkentine DP; Bridges KA; Xie T; Yang L; Sheth A; Heffernan TP; Clump DA; Faust AZ; Ferris RL; Myers JN; Frederick MJ; Mason KA; Meyn RE; Pickering CR; Skinner HD
Int J Radiat Biol; 2021; 97(8):1121-1128. PubMed ID: 32073931
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests.
Kriegs M; Kasten-Pisula U; Riepen B; Hoffer K; Struve N; Myllynen L; Braig F; Binder M; Rieckmann T; Grénman R; Petersen C; Dikomey E; Rothkamm K
Oncotarget; 2016 Jul; 7(29):45122-45133. PubMed ID: 27281611
[TBL] [Abstract][Full Text] [Related]
9. TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.
Wang L; Zhang P; Molkentine DP; Chen C; Molkentine JM; Piao H; Raju U; Zhang J; Valdecanas DR; Tailor RC; Thames HD; Buchholz TA; Chen J; Ma L; Mason KA; Ang KK; Meyn RE; Skinner HD
Oncogene; 2017 Feb; 36(6):820-828. PubMed ID: 27425591
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas.
Göttgens EL; Bussink J; Leszczynska KB; Peters H; Span PN; Hammond EM
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):548-558. PubMed ID: 31271827
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells.
Sørensen BS; Busk M; Olthof N; Speel EJ; Horsman MR; Alsner J; Overgaard J
Radiother Oncol; 2013 Sep; 108(3):500-5. PubMed ID: 23953409
[TBL] [Abstract][Full Text] [Related]
12. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.
Vlashi E; Chen AM; Boyrie S; Yu G; Nguyen A; Brower PA; Hess CB; Pajonk F
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1198-206. PubMed ID: 27026319
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous cell carcinoma cell lines exposed to carbon ions and x-rays.
Maalouf M; Alphonse G; Colliaux A; Beuve M; Trajkovic-Bodennec S; Battiston-Montagne P; Testard I; Chapet O; Bajard M; Taucher-Scholz G; Fournier C; Rodriguez-Lafrasse C
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):200-9. PubMed ID: 19362238
[TBL] [Abstract][Full Text] [Related]
14. Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells.
Klieber N; Hildebrand LS; Faulhaber E; Symank J; Häck N; Härtl A; Fietkau R; Distel LV
Cells; 2024 Feb; 13(4):. PubMed ID: 38391917
[TBL] [Abstract][Full Text] [Related]
15. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
16. Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines.
Busch CJ; Becker B; Kriegs M; Gatzemeier F; Krüger K; Möckelmann N; Fritz G; Petersen C; Knecht R; Rothkamm K; Rieckmann T
Oncotarget; 2016 Jun; 7(24):35832-35842. PubMed ID: 27127883
[TBL] [Abstract][Full Text] [Related]
17. In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status.
Reid P; Wilson P; Li Y; Marcu LG; Staudacher AH; Brown MP; Bezak E
PLoS One; 2017; 12(10):e0186186. PubMed ID: 29028842
[TBL] [Abstract][Full Text] [Related]
18. BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma.
Wang F; Wang J; Wang J; Zhang L; Fu H; Li J; Tian T; Zuo J; Lv W; Ma X
Biochem Biophys Res Commun; 2020 Aug; 529(3):685-691. PubMed ID: 32736693
[TBL] [Abstract][Full Text] [Related]
19. Small molecules alter VEGFR and PTEN expression in HPV-positive and -negative SCC: new hope for targeted-therapy.
Aderhold C; Faber A; Umbreit C; Chakraborty A; Bockmayer A; Birk R; Sommer JU; Hörmann K; Schultz JD
Anticancer Res; 2015 Mar; 35(3):1389-99. PubMed ID: 25750290
[TBL] [Abstract][Full Text] [Related]
20. Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines.
Ziemann F; Seltzsam S; Dreffke K; Preising S; Arenz A; Subtil FSB; Rieckmann T; Engenhart-Cabillic R; Dikomey E; Wittig A
Oncotarget; 2017 Dec; 8(62):105170-105183. PubMed ID: 29285242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]